Show simple item record

dc.contributor.authorHeidenreich, A.
dc.contributor.authorParente, P.
dc.contributor.authorde Schultz, W.
dc.contributor.authorGerritsen, W. R.
dc.contributor.authorAnton Aparicio, L. M.
dc.contributor.authorMalik, Z. I.
dc.contributor.authorDi Lorenzo, G.
dc.contributor.authorBasaran, M.
dc.contributor.authorHitier, S.
dc.contributor.authorBahl, A.
dc.date.accessioned2021-03-03T08:23:41Z
dc.date.available2021-03-03T08:23:41Z
dc.identifier.citationMalik Z. I. , Di Lorenzo G., Basaran M., Parente P., de Schultz W., Gerritsen W. R. , Anton Aparicio L. M. , Hitier S., Heidenreich A., Bahl A., "CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)", 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.306-307
dc.identifier.othervv_1032021
dc.identifier.otherav_1747af23-469b-4ff4-b34e-5edb3101adbd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/21014
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleCABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)
dc.typeBildiri
dc.contributor.departmentClatterbridge Canc Ctr NHS Fdn Trust , ,
dc.identifier.volume23
dc.contributor.firstauthorID140094


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record